The State Institute for Drug Control (SÚKL) is an essential institution in the Czech Republic, dedicated to ensuring the safety and efficacy of pharmaceuticals and medical devices. SÚKL serves various stakeholders, including the public, healthcare professionals, and the pharmaceutical industry. They offer a wide array of services, such as the approval and monitoring of medicinal products, maintaining comprehensive drug databases, and providing information on drug availability and regulatory compliance.

One of SÚKL's primary functions is the assessment and regulation of medications to guarantee their quality and safety for consumers. They continuously work on pharmacovigilance, responding to adverse drug reactions, and educating stakeholders on important medical information. The institute also plays a vital role in regulatory decisions regarding medical products and facilitates consultations within the healthcare sector. With an aim to enhance public health, SÚKL is committed to transparency and accessibility of information, reflected through regular updates and outreach initiatives.